News for Healthier Living

Study Reveals Weight Loss Medications May Improve Outcomes for Chronic Sinus Disease Patients

A new study published in Otolaryngology-Head and Neck Surgery, the peer-reviewed journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation, reveals that glucagon-like peptide-1 receptor agonists (GLP-1RAs)--a class of medications primarily used for weight loss and diabetes management--may significantly improve post-surgical outcomes for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and obesity.

January 22, 2026


January 22 2026

January 21 2026

January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026